Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
robotic assistive technology for cochlear implant electrode insertion
University of Iowa
Iowa City, Iowa, United States
Texas Childrens Hospital
Houston, Texas, United States
iotaSOFT Related-serious Adverse Events Measured by Calculating the Proportion of Subjects With One or More SAEs.
The primary endpoint of the study was to demonstrate safety of the iotaSOFT Insertion System through evaluation of iotaSOFT related serious adverse events through 30 days after CI surgery/activation.
Time frame: (SAEs) through 30 days after CI surgery/activation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.